Results 191 to 200 of about 142,846 (219)

Single‐Dose TACE‐Like Injection of Sustained‐Release Panobinostat/IL‐12 Polymeric Microparticles is Effective in Preclinical Liver Cancer Models

Advanced Science, EarlyView.
A novel PLGA/PBAE polymer microparticle platform revolutionizes intermediate‐stage liver cancer treatment by co‐delivering panobinostat and IL‐12 via a single TACE‐like injection. This sustained‐release system overcomes tumor immunosuppression, triggers robust innate and adaptive immune responses, and establishes tertiary lymphoid structures ...
Hongzhe Yu, Ling Li, Sachin S. Surwase, Xin Ming M. Zhou, Hongtao Qian, Joel C. Sunshine, Florin M. Selaru, Jordan J. Green   +7 more
wiley   +1 more source

Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy. [PDF]

Exp Hematol Oncol
Riet T, Lennartz S, Bösing N, Prinz LF, Dähn L, Scheid C, Hallek M, Chmielewski MM.   +7 more
europepmc   +1 more source

A Drug‐Gated, Modular STAb‐T Immunotherapy With External Control

Advanced Science, EarlyView.
Engineered STAb‐TON cells act as programmable living factories that continuously secrete inactive antibody modules, which assemble extracellularly into a functional T cell engager only upon small‐molecule administration. This externally controlled platform enables reversible, on‐demand regulation of antitumor immunity, establishing a new paradigm for ...
Susana Luengo‐Arias, Carmen Domínguez‐Alonso, Ivana Zagorac, Antonio Tapia‐Galisteo, Eva García‐Veros, Laura Rubio‐Pérez, Marina Gómez‐Rosel, Patricia Fuentes, Patricia Hernández‐López, Óscar Aguilar‐Sopeña, Laura Almagro‐Puente, Sonia Martínez‐González, Lucía Cañizares‐Moscato, María Rivas‐Sánchez, Belén Blanco, Ángel Ramírez‐Fernández, Laura Díez‐Alonso, Carmen Blanco‐Aparicio, Javier Arroyo‐Ródenas, Jorge Martínez‐Torrecuadrada, María L. Toribio, Pedro Roda‐Navarro, Anaïs Jiménez‐Reinoso, Luis Álvarez‐Vallina   +23 more
wiley   +1 more source

Immunotheranostics in Solid Tumors: Longitudinal Tracking of Human IL13Rα2 CAR-T Cells In Vivo. [PDF]

J Nucl Med
Mirzaei HR, Lovibond S, Gajecki L, Qureshy S, Kumpf M, Jeanjean P, Lee SG, Cai W, Miranda I, Mauguen A, Carter LM, Schöder H, Veach DR, Scheinberg DA, Krebs S.   +14 more
europepmc   +1 more source

Generation of CCR4/CD7 Bispecific CAR-T Cells Resistant to Fratricide and Exhaustion. [PDF]

Adv Sci (Weinh)
Li S, Li Y, Rashid A, Tan HK, Chan S, Hui MY, Chan WYK, Lam KS, Liu Y, Tu W, Leung W.   +10 more
europepmc   +1 more source

Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistence. [PDF]

Blood
Durgin JS, Seo S, Kazmi S, Valentic B, Leff C, Markovska M, Jin X, Shen F, Berjis A, Mukherjee N, Sannecy A, Plesa G, Gabunia K, Scholler J, Gill SI, O'Connor RS, June CH, Ghassemi S.   +17 more
europepmc   +1 more source

Pretreatment With BTK Inhibitors Improved the Sensitivity of DLBCL Cells to CAR-T Cells in a Coculture System by Downregulating the Polarisation of M2 Macrophages. [PDF]

J Cell Mol Med
Qi Y, Fan X, Wang J, Li X, Mu J, Cui R, Deng Q.   +6 more
europepmc   +1 more source

Editorial: Innovations in development, translational research and manufacturing of CAR T cells. [PDF]

Front Immunol
Krones D, Koehl U, Negre H, Rafiq Q, Goldrick S, Hudecek M.   +5 more
europepmc   +1 more source

Advanced strategies to enhance the safety, persistence, and efficacy of CAR-T cells in solid tumors. [PDF]

Front Immunol
Ajmal I, Du B, Huang N, Huang Q, Jiang D, Farooq MA, Xu G.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Critical care management of chimeric antigen receptor T-cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Sandrine Valade, Peter Schellongowski, Alexander Shimabukuro-Vornhagen   +2 more
exaly